CD8A and melanoma: To further identify the major changes in CD8+ T cells composition, effector programs, and molecular pathways underlying colitis induced by ICI treatment, we re-analyzed the single-cell RNA sequence data from healthy donors, ICI-treated melanoma patients with colitis or without colitis (GEO: GSE144469) (15).